531 related articles for article (PubMed ID: 35170996)
1. Bacteriocin-Based Synergetic Consortia: a Promising Strategy to Enhance Antimicrobial Activity and Broaden the Spectrum of Inhibition.
Soltani S; Biron E; Ben Said L; Subirade M; Fliss I
Microbiol Spectr; 2022 Feb; 10(1):e0040621. PubMed ID: 35170996
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory Activity of Natural Synergetic Antimicrobial Consortia Against
Zhang L; Ben Said L; Diarra MS; Fliss I
Front Microbiol; 2021; 12():656956. PubMed ID: 33995320
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Antimicrobial Activity Between the Broad Spectrum Bacteriocin Garvicin KS and Nisin, Farnesol and Polymyxin B Against Gram-Positive and Gram-Negative Bacteria.
Chi H; Holo H
Curr Microbiol; 2018 Mar; 75(3):272-277. PubMed ID: 29058043
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of MRSA and of Clostridium difficile by durancin 61A: synergy with bacteriocins and antibiotics.
Hanchi H; Hammami R; Gingras H; Kourda R; Bergeron MG; Ben Hamida J; Ouellette M; Fliss I
Future Microbiol; 2017 Mar; 12():205-212. PubMed ID: 28262046
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of reuterin in combination with nisin against food-borne pathogens.
Arqués JL; Fernández J; Gaya P; Nuñez M; Rodríguez E; Medina M
Int J Food Microbiol; 2004 Sep; 95(2):225-9. PubMed ID: 15282134
[TBL] [Abstract][Full Text] [Related]
6. Synergistically-acting Enterocin LD3 and Plantaricin LD4 Against Gram-Positive and Gram-Negative Pathogenic Bacteria.
Sheoran P; Tiwari SK
Probiotics Antimicrob Proteins; 2021 Apr; 13(2):542-554. PubMed ID: 32918678
[TBL] [Abstract][Full Text] [Related]
7. In vitro inhibition activity of nisin A, nisin Z, pediocin PA-1 and antibiotics against common intestinal bacteria.
Le Blay G; Lacroix C; Zihler A; Fliss I
Lett Appl Microbiol; 2007 Sep; 45(3):252-7. PubMed ID: 17718835
[TBL] [Abstract][Full Text] [Related]
8. In vitro assessment of skin sensitization, irritability and toxicity of bacteriocins and reuterin for possible topical applications.
Soltani S; Boutin Y; Couture F; Biron E; Subirade M; Fliss I
Sci Rep; 2022 Mar; 12(1):4570. PubMed ID: 35301365
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of MccJ25(G12Y) against gram-negative foodborne pathogens in vitro and in food models.
Corbalán N; Quiroga M; Masias E; Peralta D; Barros Velázquez J; Acuña L; Vincent P
Int J Food Microbiol; 2021 Aug; 352():109267. PubMed ID: 34102464
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal Stability and Cytotoxicity of Bacteriocins From Gram-Positive and Gram-Negative Bacteria: A Comparative
Soltani S; Zirah S; Rebuffat S; Couture F; Boutin Y; Biron E; Subirade M; Fliss I
Front Microbiol; 2021; 12():780355. PubMed ID: 35145490
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of commercial natural antimicrobials alone and in combinations against pathogenic and spoilage microorganisms.
Techathuvanan C; Reyes F; David JR; Davidson PM
J Food Prot; 2014 Feb; 77(2):269-75. PubMed ID: 24490921
[TBL] [Abstract][Full Text] [Related]
12. Improved antimicrobial activities of synthetic-hybrid bacteriocins designed from enterocin E50-52 and pediocin PA-1.
Tiwari SK; Sutyak Noll K; Cavera VL; Chikindas ML
Appl Environ Microbiol; 2015 Mar; 81(5):1661-7. PubMed ID: 25527560
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial activity of class I and IIa bacteriocins combined with polymyxin E against resistant variants of Listeria monocytogenes and Escherichia coli.
Naghmouchi K; Belguesmia Y; Baah J; Teather R; Drider D
Res Microbiol; 2011; 162(2):99-107. PubMed ID: 20868743
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the Potential and Synergetic Effects of Microcins against Multidrug-Resistant
Telhig S; Ben Said L; Torres C; Rebuffat S; Zirah S; Fliss I
Microbiol Spectr; 2022 Jun; 10(3):e0275221. PubMed ID: 35543514
[TBL] [Abstract][Full Text] [Related]
15. Peptide Bacteriocins--Structure Activity Relationships.
Etayash H; Azmi S; Dangeti R; Kaur K
Curr Top Med Chem; 2015; 16(2):220-41. PubMed ID: 26265354
[TBL] [Abstract][Full Text] [Related]
16. Phenomic and genomic approaches to studying the inhibition of multiresistant Salmonella enterica by microcin J25.
Ben Said L; Emond-Rheault JG; Soltani S; Telhig S; Zirah S; Rebuffat S; Diarra MS; Goodridge L; Levesque RC; Fliss I
Environ Microbiol; 2020 Jul; 22(7):2907-2920. PubMed ID: 32363677
[TBL] [Abstract][Full Text] [Related]
17. Microcin J25 Exhibits Inhibitory Activity Against
Naimi S; Zirah S; Taher MB; Theolier J; Fernandez B; Rebuffat SF; Fliss I
Front Microbiol; 2020; 11():988. PubMed ID: 32528437
[TBL] [Abstract][Full Text] [Related]
18. Novel enterocin E20c purified from Enterococcus hirae 20c synergised with ß-lactams and ciprofloxacin against Salmonella enterica.
Sharma P; Rashid M; Kaur S
Microb Cell Fact; 2020 May; 19(1):98. PubMed ID: 32366243
[TBL] [Abstract][Full Text] [Related]
19. Nisin resistance in Gram-positive bacteria and approaches to circumvent resistance for successful therapeutic use.
Barbosa AAT; de Melo MR; da Silva CMR; Jain S; Dolabella SS
Crit Rev Microbiol; 2021 May; 47(3):376-385. PubMed ID: 33689548
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting bacterial colonization on catheters: Antibacterial and antibiofilm activities of bacteriocins from Lactobacillus plantarum SJ33.
Ray Mohapatra A; Jeevaratnam K
J Glob Antimicrob Resist; 2019 Dec; 19():85-92. PubMed ID: 30853461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
